EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:90962 |
| ChEBI Name | Utibron Neohaler |
| Stars | |
| Definition | A two-drug mixture consisting of glycopyrronium bromide, a muscarinic antagonist and indacaterol, a β-2 receptor agonist; used for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease. |
| Last Modified | 18 January 2016 |
| Submitter | Steve |
| Roles Classification |
|---|
| Application: | bronchodilator agent An agent that causes an increase in the expansion of a bronchus or bronchial tubes. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Utibron Neohaler (CHEBI:90962) has part indacaterol maleate (CHEBI:68573) |
| Utibron Neohaler (CHEBI:90962) has part ritropirronium bromide (CHEBI:5494) |
| Utibron Neohaler (CHEBI:90962) has role bronchodilator agent (CHEBI:35523) |
| Utibron Neohaler (CHEBI:90962) is a mixture (CHEBI:60004) |
| Synonyms | Source |
|---|---|
| Indacaterol / glycopyrronium | ChemIDplus |
| Glycopyrrolate mixture with indacaterol | ChEBI |
| Glycopyrronium bromide / indacaterol | ChemIDplus |
| QVA 149 | ChemIDplus |
| Glycopyrrolate / indacaterol | ChemIDplus |
| QVA149 | ChemIDplus |
| Brand Names | Source |
|---|---|
| Ultibro | KEGG DRUG |
| Utibron Neohaler | KEGG DRUG |
| Glycopyrronium bromide - indacaterol maleate mixt | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| D10505 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:1262431-94-6 | ChemIDplus |
| Citations |
|---|